Immix Biopharma’s Enters into U.S. GMP Manufacturing Agreement to Expand Ongoing NXC-201 Phase 1b/2 Clinical Trial to the U.S. By Investing.com Markets February 15, 2023 [ad_1] Immix Biopharma’s (IMMX) Enters into U.S. GMP Manufacturing Settlement to Broaden Ongoing NXC-201 Part 1b/2 Medical Trial to the…
